AU7397887A - Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatment - Google Patents
Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatmentInfo
- Publication number
- AU7397887A AU7397887A AU73978/87A AU7397887A AU7397887A AU 7397887 A AU7397887 A AU 7397887A AU 73978/87 A AU73978/87 A AU 73978/87A AU 7397887 A AU7397887 A AU 7397887A AU 7397887 A AU7397887 A AU 7397887A
- Authority
- AU
- Australia
- Prior art keywords
- lipopolysaccharide
- treatment
- tumor therapy
- natural factor
- factor compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 239000002158 endotoxin Substances 0.000 title 1
- 229920006008 lipopolysaccharide Polymers 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2006—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86156686A | 1986-05-09 | 1986-05-09 | |
US861566 | 1986-05-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7397887A true AU7397887A (en) | 1987-12-01 |
Family
ID=25336155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU73978/87A Abandoned AU7397887A (en) | 1986-05-09 | 1987-05-07 | Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatment |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0271521A4 (de) |
JP (1) | JPS63503308A (de) |
AU (1) | AU7397887A (de) |
WO (1) | WO1987006830A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4844895A (en) * | 1985-11-01 | 1989-07-04 | New York University | Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses |
EP0287633B1 (de) * | 1986-10-16 | 1993-07-07 | The President And Fellows Of Harvard College | Kombinationen von nekrose-tumor-faktoren und entzündungshemmenden mitteln für die behandlung von bösartigen und nicht bösartigen erkrankungen |
US20070025958A1 (en) | 2000-10-27 | 2007-02-01 | Hadden John W | Vaccine immunotherapy |
JP2004521867A (ja) | 2000-10-27 | 2004-07-22 | イミュノ−アールエックス, インコーポレイテッド | 免疫抑制された患者のためのワクチン免疫療法 |
TW200303759A (en) * | 2001-11-27 | 2003-09-16 | Schering Corp | Methods for treating cancer |
AU2002364051A1 (en) * | 2002-01-24 | 2003-09-02 | Children's Medical Center Corporation | Anti-cancer combination and use thereof |
EP1449535B1 (de) * | 2003-02-18 | 2006-05-03 | Clinique La Prairie Research SA | Zusammensetzungen enthaltend fötales Hämoglobin und bakterielles Endotoxin und fakultativ zusätzliche fötale Leberkomponenten |
US20050059613A1 (en) * | 2003-07-08 | 2005-03-17 | Bahram Memarzadeh | Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium |
EP1881080A1 (de) | 2006-07-18 | 2008-01-23 | Institut Gustave Roussy | Funktionsstörung des Toll-ähnliches Rezeptors 4 und biologische Anwendungen davon |
WO2009070639A1 (en) | 2007-11-28 | 2009-06-04 | Irx Therapeutics, Inc. | Method of increasing immunological effect |
DK2429585T3 (en) | 2009-05-15 | 2018-07-30 | Irx Therapeutics Inc | VACCINE IMMUNOTHERAPY |
EP2510106B1 (de) | 2009-12-08 | 2018-02-14 | IRX Therapeutics, Inc. | Verfahren zur umkehrung der immunsuppression von langerhans-zellen |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH643138A5 (de) * | 1983-08-29 | 1984-05-30 | Mepha Ag | Indomethacin enthaltende, gelartige salbe. |
-
1987
- 1987-05-07 EP EP19870903576 patent/EP0271521A4/de not_active Withdrawn
- 1987-05-07 JP JP50303187A patent/JPS63503308A/ja active Pending
- 1987-05-07 WO PCT/US1987/001050 patent/WO1987006830A1/en not_active Application Discontinuation
- 1987-05-07 AU AU73978/87A patent/AU7397887A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPS63503308A (ja) | 1988-12-02 |
EP0271521A1 (de) | 1988-06-22 |
EP0271521A4 (de) | 1989-11-14 |
WO1987006830A1 (en) | 1987-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1897088A (en) | Method of treating patients suffering from chronic pain or chronic cough | |
AU7211787A (en) | Intraocular dosage compositions and method of use | |
AU7524287A (en) | Method of surface treatment and apparatus used therefor | |
AU1520188A (en) | Compositions and methods of treatment of timber | |
AU7026587A (en) | Irradiator and method of using an irradiator to irradiate | |
AU6979487A (en) | Treatment of gases | |
AU7397887A (en) | Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatment | |
AU3790489A (en) | Composition and method for treatment of gastrointestinal disorders | |
AU8013587A (en) | A method and composition for the treatment of bathtubs | |
AU6812387A (en) | Method of inducing an immunosuppressant effect using sulphamoylamino-ergo lines | |
AU1273488A (en) | Apparatus and method of creating and controlling an artificial water table | |
AU629103C (en) | Vaccine and method of preparation | |
BG41842A1 (en) | Method for simultaneous treatment of femuro- thibial and femuro- patelaric artrose | |
AU7113191A (en) | Vaccine and method of preparation | |
ZA888338B (en) | Pharmaceutical compositions and method of treatment | |
GB8822012D0 (en) | Method of treatment | |
GB8812228D0 (en) | Method of treatment | |
GB8800565D0 (en) | Method of treatment | |
GB8811006D0 (en) | Method of treatment | |
GB8811891D0 (en) | Method of treatment | |
GB8822016D0 (en) | Method of treatment | |
GB8822015D0 (en) | Method of treatment | |
GB8822014D0 (en) | Method of treatment | |
GB8822013D0 (en) | Method of treatment | |
GB8803008D0 (en) | Method of treatment |